Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trial

AIMS: The aim of this study was to generate a biomarker-driven prognostic tool for patients with chronic HFrEF. Circulating levels of N-terminal pro B-type natriuretic peptide (NT-proBNP) and high-sensitivity cardiac troponin T (hs-cTnT) each have a marked positive relationship with adverse outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Pocock, Stuart J, Ferreira, João Pedro, Gregson, John, Anker, Stefan D, Butler, Javed, Filippatos, Gerasimos, Gollop, Nicholas D, Iwata, Tomoko, Brueckmann, Martina, Januzzi, James L, Voors, Adriaan A, Zannad, Faiez, Packer, Milton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Fast Track Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599073/
https://www.ncbi.nlm.nih.gov/pubmed/34423361
http://dx.doi.org/10.1093/eurheartj/ehab579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599073/
https://www.ncbi.nlm.nih.gov/pubmed/34423361
http://dx.doi.org/10.1093/eurheartj/ehab579

Ejemplares similares